@incollection{,
	
					
					
					2155265EE3B926294E33A758C5CA9126
				,
	author={{RomanAnton} and {The University of Truth and Common Sense, International}},
	journal={{Global Journal of Medical Research}},
	journal={{GJMR}}2249-46180975-588810.34257/GJMR,
	address={Cambridge, United States},
	publisher={Global Journals Organisation}1823356
}

@incollection{b0,
	
	
		,
	title={{The Journey from Discoveries in Fundamental Immunology to Cancer Immunotherapy}}
		,
	author={{
			JMiller
		} and {
			MSadelain
		}}
		
	
	
		,
	journal={{Cancer Cell}}
		
			27
			4
			
			,
	year={2015}
		
	

}

@incollection{b1,
	
	
		,
	title={{Novel cancer immunotherapy agents with survival benefit: recent successes and next steps}}
		,
	author={{
			PSharma
		} and {
			KWagner
		} and {
			JWolchok
		} and {
			JAllison
		}}
		
		
		
	
	
		,
	journal={{Nat Rev Cancer}}
		
			11
			11
			
			,
	year={2011}
		
	

}

@incollection{b2,
	
	
		,
	title={{RNA-Based Vaccines in Cancer Immunotherapy}}
		,
	author={{
			MMcnamara
		} and {
			SNair
		} and {
			KEda
		}}
		
		
	
	
		,
	journal={{J. Immunol. Res}}
		
			794528
			
			,
	year={2015}
		
	

}

@incollection{b3,
	
	
		,
	title={{Combination immunotherapy: a road map}}
		,
	author={{
			APatrick
		} and {
			FHodi
		} and {
			HKaufman
		} and {
			JWigginton
		} and {
			JWolchok
		}}
		
		
		
		
	
	
		,
	journal={{J Immunother Cancer}}
		
			5
			16
			
			,
	year={2017}
		
	

}

@incollection{b4,
	
	
		,
	title={{}}
	
	
		,
	journal={{Nature Reviews -Focus on Tumor Immunology and Immunotherapy}}
		
			12
			4
			,
	year={2012}
		
	
	,
	note={Nat Rev Immunol}

}

@incollection{b5,
	
	
		,
	title={{}}
		,
	author={{
			ASukari
		} and {
			MNagasaka
		} and {
			AAl-Hadidi
		} and {
			LLum
		}}
		
		
		
	
	
		,
	journal={{Cancer Immunology and Immunotherapy}}
		
	

}

@incollection{b6,
	
	
		,
	title={{}}
	
	
		,
	journal={{Anticancer Res}}
		
			36
			11
			
			,
	year={2016}
		
	

}

@incollection{b7,
	
	
		,
	title={{Cancer immunotherapy: harnessing the immune system to battle cancer}}
		,
	author={{
			YYang
		}}
	
	
		,
	journal={{J Clin Invest}}
		
			125
			9
			
			,
	year={2015}
		
	

}

@incollection{b8,
	
	
	
	
		,
	booktitle={{Special Feature}}
				
			,
	year={2015}
		
	
	,
	note={Cell Press}

}

@incollection{b9,
	
	
		,
	title={{Advances in cancer immunology and cancer immunotherapy}}
		,
	author={{
			CVoena
		} and {
			RChiarle
		}}
		
	
	
		,
	journal={{Discov Med}}
		
			21
			114
			
			,
	year={2016}
		
	

}

@incollection{b10,
	
	
		,
	author={{
			KDMiller
		}}
	
	
		,
	booktitle={{Cancer treatment and survivorship statistics}}
				
			,
	year={2016. 2016}
			66
			
		
	
	,
	note={11. FDA, "FDA drug approvals," 2018. [Online}

}

@incollection{b11,
	
	
		,
	title={{Global Cancer Immunotherapy Market Analysis & Forecast to 2022 -Kelly Scientific Publications}}
	
	
		,
	journal={{KSP}}
		
			,
	year={2017}
		
	

}

@incollection{b12,
	
	
		,
	title={{The top 15 best-selling cancer drugs in 2022}}
		,
	author={{
			PTaylor
		}}
	
	
		,
	booktitle={{Fierce Markets}}
		
			
			,
	year={2017}
		
	

}

@incollection{b13,
	
	
		,
	title={{When Quality Beats Quantity: Decision Theory, Drug Discovery, and the Reproducibility Crisis}}
		,
	author={{
			JScannell
		} and {
			JBosley
		}}
		
	
	
		,
	journal={{PLoS One}}
		
			11
			2
			
			,
	year={2016}
		
	

}

@incollection{b14,
	
	
		,
	title={{Exploration and exploitation in organizational learning}}
		,
	author={{
			JGMarch
		}}
	
	
		,
	journal={{Organ. Sci}}
		
			2
			1
			
			,
	year={1991}
		
	

}

@incollection{b15,
	
	
		,
	title={{How top management team behavioral integration and behavioral complexity enable organizational ambidexterity: The moderating role of contextual ambidexterity}}
		,
	author={{
			ACarmeli
		} and {
			MYHalevi
		}}
		
	
	
		,
	journal={{Leadersh. Q}}
		
			20
			2
			
			,
	year={2009}
		
	

}

@incollection{b16,
	
	
		,
	title={{An Advancement of Entrepreneurship and Harvard Strategy: GSI and ISF}}
		,
	author={{
			R
		} and {
			Anton
		}}
		
	
	
		,
	journal={{LAP}}
		
			1
			1
			,
	year={2016}
		
	

}

@incollection{b17,
	
	
		,
	title={{Increasing Transparency of Clinical Trial Data in the United States and the European Union}}
		,
	author={{
			RChoi
		}}
	
	
		,
	journal={{Wash U Glob. Stud L Rev}}
		
			14
			3
			
			,
	year={2015}
		
	

}

@incollection{b18,
	
	
		,
	title={{Vaccines for tumor prevention: a pipe dream?}}
		,
	author={{
			GForni
		}}
	
	
		,
	journal={{J Infect Dev Ctries}}
		
			9
			6
			
			,
	year={2015}
		
	

}

@incollection{b19,
	
	
		,
	title={{Three major uncertainties in the antibody therapy of cancer}}
		,
	author={{
			GStevenson
		}}
	
	
		,
	journal={{Haematologica}}
		
			99
			10
			
			,
	year={2014}
		
	

}

@incollection{b20,
	
	
		,
	title={{Immunotoxicity of monoclonal antibodies}}
		,
	author={{
			JDescotes
		}}
	
	
		,
	journal={{MAbs}}
		
			1
			2
			
			,
	year={2009}
		
	

}

@incollection{b21,
	
	
		,
	title={{Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies}}
		,
	author={{
			FBrennan
		}}
	
	
		,
	journal={{MAbs}}
		
			2
			3
			27
			,
	year={2010}
		
	

}

@incollection{b22,
	
	
		,
	title={{Current concepts in the diagnosis and management of cytokine release syndrome}}
		,
	author={{
			DLee
		}}
	
	
		,
	journal={{Blood}}
		
			124
			
			,
	year={2014}
		
	

}

@incollection{b23,
	
	
		,
	title={{Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged mice}}
		,
	author={{
			AMirsoian
		}}
	
	
		,
	journal={{JEM}}
		
			211
			12
			2373
			,
	year={2014}
		
	

}

@incollection{b24,
	
	
		,
	title={{Engineering of Fc Fragments with Optimized Physicochemical Properties Implying Improvement of Clinical Potentials for Fc-Based Therapeutics}}
		,
	author={{
			CYang
		} and {
			XGao
		} and {
			RGong
		}}
		
		
	
	
		,
	journal={{Front Immunol}}
		
			8
			1860
			
			,
	year={2017}
		
	

}

@incollection{b25,
	
	
		,
	title={{Too Many PhD Graduates or Too Few Academic Job Openings: The Basic Reproductive Number R0 in Academia}}
		,
	author={{
			RLarson
		} and {
			NGhaffarzadegan
		} and {
			YXue
		}}
		
		
	
	
		,
	journal={{Syst Res Behav Sci}}
		
			31
			6
			
			,
	year={2015}
		
	

}

@incollection{b26,
	
	
		,
	title={{Rescuing US Biomedical Research From Its Systemic Flaws}}
		,
	author={{
			BAlberts
		} and {
			MWKirschner
		} and {
			STilghman
		} and {
			HVarmus
		}}
		
		
		
	
	
		,
	journal={{PNAS}}
		
			111
			16
			
			,
	year={2014}
		
	

}

@incollection{b27,
	
	
		,
	title={{Exploitation of junior scientists must end}}
		,
	author={{
			TShinbrot
		}}
	
	
		,
	journal={{Nature}}
		
			521
			399
			
			,
	year={1999}
		
	

}

@book{b28,
	
	
		,
	title={{Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancer}}
		,
	author={{
			SMeyer
		} and {
			JLeusen
		} and {
			PBoross
		}}
		
		
		
			,
	year={2014}
			
		
	

}

@incollection{b29,
	
	
		,
	title={{Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions}}
		,
	author={{
			GMoore
		} and {
			HChen
		} and {
			SKarki
		} and {
			GLazar
		}}
		
		
		
	
	
		,
	journal={{MAbs}}
		
			2
			2
			
			,
	year={2010}
		
	

}

@incollection{b30,
	
	
		,
	title={{Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor}}
		,
	author={{
			EWalter
		}}
	
	
		,
	journal={{N Engl J Med}}
		
			333
			16
			
			,
	year={1995}
		
	

}

@book{b31,
	
	
		,
	title={{Timeline of Cancer Immunotherapy}}
		
		
			,
	year={2018}
		
		
			CRI
		
	
	,
	note={Major Discovery}

}

@incollection{b32,
	
	
		,
	title={{Costimulatory pathways in transplantation}}
		,
	author={{
			NPilat
		} and {
			MSayegh
		} and {
			TWekerlea
		}}
		
		
	
	
		,
	journal={{Semin Immunol}}
		
			23
			4
			
			,
	year={2011}
		
	

}

@incollection{b33,
	
	
		,
	title={{Adoptive cell transfer: a clinical path to effective cancer immunotherapy}}
		,
	author={{
			SRosenberg
		} and {
			NRestifo
		} and {
			JYang
		} and {
			RMorgan
		} and {
			MDudley
		}}
		
		
		
		
	
	
		,
	journal={{Nat Rev Cancer}}
		
			8
			4
			
			,
	year={2008}
		
	

}

@incollection{b34,
	
	
		,
	title={{Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction}}
		,
	author={{
			WHo
		} and {
			JBlattman
		} and {
			MDossett
		} and {
			CYee
		} and {
			PGreenberg
		}}
		
		
		
		
	
	
		,
	journal={{Cancer Cell}}
		
			3
			5
			
			,
	year={2003}
		
	

}

@incollection{b35,
	
	
		,
	title={{Adoptive T cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology}}
		,
	author={{
			MKalos
		} and {
			CJune
		}}
		
	
	
		,
	journal={{Immunity}}
		
			39
			1
			
			,
	year={2014}
		
	

}

@incollection{b36,
	
	
		,
	title={{Current advances in T-cell-based cancer immunotherapy}}
		,
	author={{
			MWang
		} and {
			BYin
		} and {
			HWang
		} and {
			RWang
		}}
		
		
		
	
	
		,
	journal={{Immunotherapy}}
		
			6
			12
			
			,
	year={2014}
		
	

}

@book{b37,
	
	
		,
	title={{Adoptive cell transfer as personalized immunotherapy for human cancer}}
		,
	author={{
			SRosenberg
		} and {
			NRestifo
		}}
		
		
			,
	year={2015}
			348
			
		
	

}

@incollection{b38,
	
	
		,
	title={{PD-1(hi)TIM-3(+) T cells associate with and predict leukemia relapse in AML patients post allogeneic stem cell transplantation}}
		,
	author={{
			YKong
		}}
	
	
		,
	journal={{Blood Cancer J}}
		
			5
			e330
			
			,
	year={2015}
		
	

}

@incollection{b39,
	
	
		,
	title={{The allogeneic graft-versus-cancer effect}}
		,
	author={{
			ORingdén
		} and {
			HKarlsson
		} and {
			ROlsson
		} and {
			BOmazic
		} and {
			MUhlin
		}}
		
		
		
		
	
	
		,
	journal={{Br J Haematol}}
		
			147
			5
			
			,
	year={2009}
		
	

}

@incollection{b40,
	
	
		,
	title={{Adoptive cell transfer for patients with metastatic melanoma: the potential and promise of cancer immunotherapy}}
		,
	author={{
			GPhan
		} and {
			SRosenberg
		}}
		
	
	
		,
	journal={{Cancer Control}}
		
			20
			4
			
			,
	year={2013}
		
	

}

@book{b41,
	
	
		,
	title={{The open innovation revolution -Esssentials, roadblocks, and leadership skills}}
		,
	author={{
			SLindegaard
		}}
		
			,
	year={2010}
			,
	publisher={John Wiley & Sons, Inc}
			8
			,
	address={Hoboken, New Jersey, USA}
		
	

}

@book{b42,
	
	
		,
	title={{Open Innovation: the new imperative for creating and profiting from technology}}
		,
	author={{
			HWChesbrough
		}}
		
			,
	year={2003}
			,
	publisher={HBS}
			,
	address={Boston}
		
	

}

@incollection{b43,
	
	
		,
	title={{T-cell exhaustion in the tumor microenvironment}}
		,
	author={{
			YJiang
		} and {
			BZhou
		}}
		
		e1792
	
	
		,
	journal={{Cell Death Dis}}
		
			6
			
			,
	year={2015}
		
	

}

@incollection{b44,
	
	
		,
	title={{The allogeneic effect revisited: exogenous help for endogenous, tumor-specific T cells}}
		,
	author={{
			HSymons
		}}
	
	
		,
	journal={{Biol Bood}}
		
			14
			5
			28
			,
	year={2008}
		
	

}

@incollection{b45,
	
	
		,
	title={{Inflammatory Cytokines as a Third Signal for T Cell Activation}}
		,
	author={{
			JCurtsinger
		} and {
			MMescher
		}}
		
	
	
		,
	journal={{Curr Opin Immunol}}
		
			22
			3
			
			,
	year={2016}
		
	

}

@incollection{b46,
	
	
		,
	title={{A Three-cell Model for Activation of Naive T Helper Cells}}
		,
	author={{
			ACorthay
		}}
	
	
		,
	journal={{Scand J Immunol}}
		
			64
			2
			
			,
	year={2006}
		
	

}

@incollection{b47,
	
	
		,
	title={{Different Subsets of T Cells, Memory, Effector Functions, and CAR-T Immunotherapy}}
		,
	author={{
			VGolubovskaya
		} and {
			LWu
		}}
		
	
	
		,
	journal={{Cancers (Basel)}}
		
			8
			36
			
			,
	year={2016}
		
	

}

@incollection{b48,
	
	
		,
	title={{Therapeutic Cancer Vaccines: Past, Present and Future}}
		,
	author={{
			GChunqing
		} and {
			MManjili
		} and {
			RJohn
		} and {
			SDevanand
		} and {
			BPaul
		} and {
			XWang
		}}
		
		
		
		
		
	
	
		,
	journal={{Adv Cancer Rev}}
		
			119
			
			,
	year={2014}
		
	

}

@incollection{b49,
	
	
		,
	title={{Peptide-based vaccines for cancer therapy}}
		,
	author={{
			GParmiani
		} and {
			VRusso
		} and {
			CMaccalli
		} and {
			DParolini
		} and {
			NRizzo
		} and {
			MMaio
		}}
		
		
		
		
		
	
	
		,
	journal={{Hu Vaccin Immunother}}
		
			10
			11
			
			,
	year={2015}
		
	

}

@incollection{b50,
	
	
		,
	title={{Tumor cell lysates as immunogenic sources for cancer vaccine design}}
		,
	author={{
			FGonzález
		} and {
			AGleisner
		} and {
			FFalcón-Beas
		} and {
			FOsorio
		} and {
			NLópez
		} and {
			FSalazar-Onfray
		}}
		
		
		
		
		
	
	
		,
	journal={{Hum Vaccin Imunother}}
		
			10
			11
			
			,
	year={2014}
		
	

}

@book{b51,
	
	
		,
	title={{Virus-like particle display of HER2 induces potent anti-cancer responses}}
		,
	author={{
			APalladini
		}}
		
	

}

@book{b52,
	
	
		,
	title={{}}
		,
	author={{
			Oncoimmunology
		}}
		
			,
	year={2018}
			7
			e1408749
		
	

}

@incollection{b53,
	
	
		,
	title={{Prime-boost strategies in DNA vaccines}}
		,
	author={{
			CDale
		}}
	
	
		,
	journal={{Methods Mol Med}}
		
			127
			
			,
	year={2006}
		
	

}

@incollection{b54,
	
	
		,
	title={{Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8+ T Cells}}
		,
	author={{
			BXiang
		} and {
			RTrevor
		} and {
			LBaybutt
		} and {
			VAlexeev
		} and {
			ASnook
		}}
		
		
		
		
	
	
		,
	journal={{J Immunol}}
		
			198
			9
			
			,
	year={2017}
		
	

}

@incollection{b55,
	
	
		,
	title={{Sipuleucel-T immunotherapy for castrationresistant prostate cancer. A systematic review and meta-analysis}}
		,
	author={{
			PKawalec
		} and {
			APaszulewicz
		} and {
			PHolko
		} and {
			APilc
		}}
		
		
		
	
	
		,
	journal={{Arch Med Sci}}
		
			8
			5
			
			,
	year={2012}
		
	

}

@incollection{b56,
	
	
		,
	title={{Identifying and Avoiding Bias in Research}}
		,
	author={{
			CPannucci
		} and {
			EWilkins
		}}
		
	
	
		,
	journal={{Plast. Reconst. Surg}}
		
			126
			2
			
			,
	year={2011}
		
	

}

@incollection{b57,
	
	
		,
	title={{Publication prejudices: An experimental study of confirmatory bias in the peer review system}}
		,
	author={{
			MJMahoney
		}}
	
	
		,
	journal={{Cognit. Ther. Res}}
		
			1
			2
			
			,
	year={1977}
		
	

}

@incollection{b58,
	
	
		,
	title={{Falseness in the miRNA-Field as an Indicator of Strategic Bias in the Research System via Peer-Review and Publishing Eligibility}}
		,
	author={{
			R
		} and {
			Anton
		}}
		
	
	
		,
	journal={{J Invest Genomics}}
		
			4
			3
			
			,
	year={2017}
		
	

}

@incollection{b59,
	
	
		,
	title={{Publication Bias in Meta-Analysis -Prevention}}
		,
	author={{
			HRothstein
		} and {
			AJSutton
		} and {
			MBorenstein
		}}
		
		
	
	
		,
	journal={{Assessment and Adjustments}}
		
			,
	year={2005}
			,
	publisher={Wiley}
		
	

}

@incollection{b60,
	
	
		,
	title={{Why most published research findings are false}}
		,
	author={{
			JP AIoannidis
		}}
	
	
		,
	journal={{PLoS Med}}
		
			2
			8
			e124
			,
	year={Aug. 2005}
		
	

}

@incollection{b61,
	
	
		,
	title={{A fair deal for PhD students and postdocs}}
		,
	author={{
			HBourne
		}}
	
	
		,
	booktitle={{Elife}}
				
			,
	year={2013}
			1
		
	

}

@incollection{b62,
	
	
		,
	title={{Cancer immunotherapy: Strategies for personalization and combinatorial approaches}}
		,
	author={{
			VSathyanarayanan
		} and {
			SNeelapu
		}}
		
	
	
		,
	journal={{Mol Oncol}}
		
			9
			10
			
			,
	year={2015}
		
	

}

@incollection{b63,
	
	
		,
	title={{Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC)}}
		,
	author={{
			IMoya-Horno
		} and {
			SViteri
		} and {
			NKarachaliou
		} and {
			RRosell
		}}
		
		
		
	
	
		,
	journal={{Ther Adv Med Oncol}}
		
			10
			
			,
	year={2018}
		
	

}